Tachykinin receptors as drug targets for motility disorders

Willemijntje A. Hoogerwerf, Sushil K. Sarna

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The tachykinins and their receptors are strategically distributed within the gut wall, spinal cord, and central nervous system to be potential targets of therapeutic agents for gastrointestinal motility disorders. However, the development of effective tachykinin receptor agonists or antagonists to treat these disorders has had very limited success so far. This is, in part, due to the complex and multilevel of regulation of gastrointestinal motility function and the challenges faced in targeting the specific type of gut contraction to normalize function in disease state.

Original languageEnglish (US)
Pages (from-to)83-90
Number of pages8
JournalDigestive Diseases
Volume24
Issue number1-2
DOIs
StatePublished - May 2006

Fingerprint

Tachykinin Receptors
Gastrointestinal Motility
Pharmaceutical Preparations
Spinal Cord
Central Nervous System
Therapeutics

Keywords

  • Gastrointestinal motility
  • Inflammatory bowel disease
  • Irritable bowel syndrome
  • Prokinetics agents
  • Tachykinins

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Tachykinin receptors as drug targets for motility disorders. / Hoogerwerf, Willemijntje A.; Sarna, Sushil K.

In: Digestive Diseases, Vol. 24, No. 1-2, 05.2006, p. 83-90.

Research output: Contribution to journalArticle

Hoogerwerf, Willemijntje A. ; Sarna, Sushil K. / Tachykinin receptors as drug targets for motility disorders. In: Digestive Diseases. 2006 ; Vol. 24, No. 1-2. pp. 83-90.
@article{b2b716a8931d46e9a93d85832f131dce,
title = "Tachykinin receptors as drug targets for motility disorders",
abstract = "The tachykinins and their receptors are strategically distributed within the gut wall, spinal cord, and central nervous system to be potential targets of therapeutic agents for gastrointestinal motility disorders. However, the development of effective tachykinin receptor agonists or antagonists to treat these disorders has had very limited success so far. This is, in part, due to the complex and multilevel of regulation of gastrointestinal motility function and the challenges faced in targeting the specific type of gut contraction to normalize function in disease state.",
keywords = "Gastrointestinal motility, Inflammatory bowel disease, Irritable bowel syndrome, Prokinetics agents, Tachykinins",
author = "Hoogerwerf, {Willemijntje A.} and Sarna, {Sushil K.}",
year = "2006",
month = "5",
doi = "10.1159/000090311",
language = "English (US)",
volume = "24",
pages = "83--90",
journal = "Digestive Diseases",
issn = "0257-2753",
publisher = "S. Karger AG",
number = "1-2",

}

TY - JOUR

T1 - Tachykinin receptors as drug targets for motility disorders

AU - Hoogerwerf, Willemijntje A.

AU - Sarna, Sushil K.

PY - 2006/5

Y1 - 2006/5

N2 - The tachykinins and their receptors are strategically distributed within the gut wall, spinal cord, and central nervous system to be potential targets of therapeutic agents for gastrointestinal motility disorders. However, the development of effective tachykinin receptor agonists or antagonists to treat these disorders has had very limited success so far. This is, in part, due to the complex and multilevel of regulation of gastrointestinal motility function and the challenges faced in targeting the specific type of gut contraction to normalize function in disease state.

AB - The tachykinins and their receptors are strategically distributed within the gut wall, spinal cord, and central nervous system to be potential targets of therapeutic agents for gastrointestinal motility disorders. However, the development of effective tachykinin receptor agonists or antagonists to treat these disorders has had very limited success so far. This is, in part, due to the complex and multilevel of regulation of gastrointestinal motility function and the challenges faced in targeting the specific type of gut contraction to normalize function in disease state.

KW - Gastrointestinal motility

KW - Inflammatory bowel disease

KW - Irritable bowel syndrome

KW - Prokinetics agents

KW - Tachykinins

UR - http://www.scopus.com/inward/record.url?scp=33646742756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646742756&partnerID=8YFLogxK

U2 - 10.1159/000090311

DO - 10.1159/000090311

M3 - Article

VL - 24

SP - 83

EP - 90

JO - Digestive Diseases

JF - Digestive Diseases

SN - 0257-2753

IS - 1-2

ER -